January 2024 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-01-31, 21 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of January 2024

100

Ranked gains

+316.25%

Largest, LBPH

90.0%

Above baseline, day +5

10.5%

Median give-back, day +5

Filter and sort

100 ranked gains in January 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	LBPH	+316.25%	2024-01-02 against the close of 2023-12-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) 01/02/2024 08:00 ET premarket Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) 01/01/2024	Day +1 +271.48% 2024-01-03 Day +5 +289.72% 2024-01-09 Best close within 5 +317.91% 2024-01-05 8.4% of the move was gone five sessions later. Month end +252.24% on 2024-01-31
Close before and after $6.03 to $25.10 as traded Session open, high, low $18.48, $25.82, $16.20 Opening gap +206.47% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 45,494,279 shares, $1,141,906,403 Relative volume 542.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
2	CRBP	+249.41%	2024-01-26 against the close of 2024-01-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024 01/26/2024 07:30 ET premarket	Day +1 +120.62% 2024-01-29 Day +5 +216.59% 2024-02-02 Best close within 5 +229.27% 2024-02-01 13.2% of the move was gone five sessions later. Month end +213.86% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $8.44 to $29.49 split-adjusted Session open, high, low $16.81, $39.96, $16.25 Opening gap +99.17% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 33,290,727 shares, $981,743,539 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	MIMO	+186.09%	2024-01-17 against the close of 2024-01-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Airspan Revolutionizes Utilities Market with Groundbreaking End-to-End Solution 01/17/2024 08:41 ET premarket	Day +1 +121.07% 2024-01-18 Day +5 +136.67% 2024-01-24 Best close within 5 +174.51% 2024-01-19 26.6% of the move was gone five sessions later. Month end +194.02% on 2024-01-31
Close before and after $0.0769 to $0.2200 as traded Session open, high, low $0.2600, $0.4240, $0.2030 Opening gap +238.10% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 477,313,133 shares, $105,008,889 Relative volume 838.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	SGMT Also on the opposite board this month on both boards	+170.09%	2024-01-22 against the close of 2024-01-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH 01/22/2024 07:00 ET premarket	Day +1 +156.74% 2024-01-23 Day +5 +55.43% 2024-01-29 Best close within 5 +156.74% 2024-01-23 67.4% of the move was gone five sessions later. Month end +39.00% on 2024-01-31
Close before and after $6.82 to $18.42 split-adjusted Session open, high, low $15.00, $20.71, $12.10 Opening gap +119.94% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 36,169,406 shares, $666,240,459 Relative volume 420.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	ONMD	+168.21%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit 01/29/2024 08:00 ET premarket	Day +1 +193.66% 2024-01-30 Day +5 +136.88% 2024-02-05 Best close within 5 +270.01% 2024-01-31 18.6% of the move was gone five sessions later. Month end +270.01% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $0.5108 to $1.37 split-adjusted Session open, high, low $1.23, $1.65, $0.9822 Opening gap +140.80% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 77,679,753 shares, $106,421,262 Relative volume 954.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
6	EVAX More than one ranked move this month 2+ ranked moves	+113.43%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets 01/24/2024 08:30 ET premarket	Day +1 +88.58% 2024-01-25 Day +5 -21.24% 2024-01-31 Best close within 5 +88.58% 2024-01-25 It gave back the whole move and closed 21.24% below the pre-news price. Month end -21.24% on 2024-01-31
Close before and after $24.95 to $53.25 split-adjusted Session open, high, low $46.65, $68.05, $41.75 Opening gap +86.97% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 6,586,763 shares, $350,745,130 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	HARP	+111.94%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline 01/08/2024 07:30 ET premarket	Day +1 +111.94% 2024-01-09 Day +5 +112.51% 2024-01-16 Best close within 5 +112.80% 2024-01-10 Five sessions later the move was 0.5% bigger, at +112.51%. Month end +111.66% on 2024-01-31
Close before and after $10.55 to $22.36 as traded Session open, high, low $22.30, $22.55, $22.22 Opening gap +111.37% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 8,282,806 shares, $185,203,542 Relative volume 66.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
8	FAZE Also on the opposite board this month on both boards	+107.12%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	FaZe Clan and Rollbit Announce Multi-Million Dollar Esports Sponsorship Deal 01/23/2024 07:00 ET premarket	Day +1 +125.83% 2024-01-24 Day +5 +21.75% 2024-01-30 Best close within 5 +125.83% 2024-01-24 79.7% of the move was gone five sessions later. Month end +19.09% on 2024-01-31
Close before and after $0.1545 to $0.3200 as traded Session open, high, low $0.2312, $0.5600, $0.2060 Opening gap +49.64% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 291,741,048 shares, $93,357,135 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	AMAM	+101.54%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer 01/08/2024 07:30 ET premarket Ambrx Announces Sale to Johnson & Johnson 01/08/2024	Day +1 +102.13% 2024-01-09 Day +5 +103.08% 2024-01-16 Best close within 5 +106.09% 2024-01-11 Five sessions later the move was 1.5% bigger, at +103.08%. Month end +103.96% on 2024-01-31
Close before and after $13.63 to $27.47 as traded Session open, high, low $27.04, $27.60, $26.90 Opening gap +98.39% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 31,147,656 shares, $855,626,110 Relative volume 35.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
10	CNXA	+101.21%	2024-01-31 against the close of 2024-01-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Connexa Announces that it has regained compliance with the Nasdaq Minimum Shareholder Equity Rule 01/31/2024 09:00 ET premarket	Day +1 +104.83% 2024-02-01 Day +5 +38.43% 2024-02-07 Best close within 5 +104.83% 2024-02-01 62.0% of the move was gone five sessions later. Month end +101.21% on 2024-01-31 same session This month ended before the fifth session after the move.
Close before and after $0.1988 to $0.4000 as traded Session open, high, low $0.3761, $0.7350, $0.3351 Opening gap +89.19% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 236,162,112 shares, $94,464,845 Relative volume 243.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	KAMN	+100.85%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Kaman to be Acquired by Arcline for $1.8 Billion 01/19/2024 08:00 ET premarket	Day +1 +100.85% 2024-01-22 Day +5 +100.62% 2024-01-26 Best close within 5 +100.85% 2024-01-22 0.2% of the move was gone five sessions later. Month end +100.85% on 2024-01-31
Close before and after $22.43 to $45.05 as traded Session open, high, low $45.07, $45.26, $44.96 Opening gap +100.94% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 2,636,476 shares, $118,773,244 Relative volume 24.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	PALI Also on the opposite board this month on both boards	+84.62%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress 01/29/2024 08:05 ET premarket	Day +1 +19.98% 2024-01-30 Day +5 -1.92% 2024-02-05 Best close within 5 +19.98% 2024-01-30 It gave back the whole move and closed 1.92% below the pre-news price. Month end +15.29% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $7.80 to $14.40 split-adjusted Session open, high, low $17.55, $22.35, $13.95 Opening gap +125.00% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 9,068,019 shares, $130,579,474 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
13	SIDU Also on the opposite board this month on both boards	+67.00%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sidus Space Secures NOAA Approval to Provide Imaging Services to Government and Commercial Customers 01/03/2024 08:30 ET premarket	Day +1 +75.04% 2024-01-04 Day +5 +86.66% 2024-01-10 Best close within 5 +143.47% 2024-01-09 Five sessions later the move was 29.3% bigger, at +86.66%. Month end -31.13% on 2024-01-31
Close before and after $6.97 to $11.64 split-adjusted Session open, high, low $7.79, $13.48, $7.22 Opening gap +11.76% Close inside the session range 0.71 of the range, where 1.00 is the high Session volume 15,113,826 shares, $175,924,935 Relative volume 118.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
14	MESA Also on the opposite board this month on both boards	+49.98%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program 01/18/2024 16:20 ET after hours	Day +1 +81.22% 2024-01-22 Day +5 +54.65% 2024-01-26 Best close within 5 +81.22% 2024-01-22 Five sessions later the move was 9.3% bigger, at +54.65%. Month end +42.38% on 2024-01-31
Close before and after $9.60 to $14.40 as traded Session open, high, low $16.80, $18.75, $13.20 Opening gap +74.97% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 4,168,379 shares, $60,024,658 Relative volume 174.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	VERA	+48.71%	2024-01-25 against the close of 2024-01-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy 01/25/2024 06:30 ET premarket	Day +1 +77.32% 2024-01-26 Day +5 +123.27% 2024-02-01 Best close within 5 +123.27% 2024-02-01 Five sessions later the move was 153.1% bigger, at +123.27%. Month end +113.98% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $17.02 to $25.31 split-adjusted Session open, high, low $22.26, $26.67, $20.48 Opening gap +30.79% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 11,508,394 shares, $291,277,452 Relative volume 22.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	NUBI release reads negative	+48.66%	2024-01-11 against the close of 2024-01-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell Release reads negative, stock rose 48.66%	NUBIA BRAND INTERNATIONAL CORP. PROVIDES UPDATE ON REDEMPTION REVERSAL REQUESTS IN CONNECTION WITH CLOSING ITS BUSINESS COMBINATION 01/11/2024 14:12 ET intraday	Day +1 +98.31% 2024-01-12 Day +5 +38.14% 2024-01-19 Best close within 5 +98.31% 2024-01-12 21.6% of the move was gone five sessions later. Month end +5.98% on 2024-01-31
Close before and after $4.85 to $7.21 as traded Session open, high, low $4.84, $7.73, $4.84 Opening gap -0.21% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 291,519 shares, $2,101,852 Relative volume 19.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	FFNW	+48.03%	2024-01-11 against the close of 2024-01-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Global Credit Union and First Financial Northwest, Inc. Announce Agreement for Global Credit Union to Acquire First Financial Northwest Bank 01/11/2024 09:10 ET premarket	Day +1 +50.91% 2024-01-12 Day +5 +53.14% 2024-01-19 Best close within 5 +53.29% 2024-01-18 Five sessions later the move was 10.6% bigger, at +53.14%. Month end +52.63% on 2024-01-31
Close before and after $13.68 to $20.25 as traded Session open, high, low $20.53, $22.17, $19.20 Opening gap +50.07% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 349,152 shares, $7,070,328 Relative volume 57.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	KURA release reads negative	+46.13%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution Release reads negative, stock rose 46.13%	Kura Oncology Announces Oversubscribed $150 Million Private Placement 01/24/2024 07:00 ET premarket	Day +1 +39.57% 2024-01-25 Day +5 +50.07% 2024-01-31 Best close within 5 +55.37% 2024-01-30 Five sessions later the move was 8.5% bigger, at +50.07%. Month end +50.07% on 2024-01-31
Close before and after $13.42 to $19.61 split-adjusted Session open, high, low $18.40, $21.40, $17.81 Opening gap +37.11% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 16,113,089 shares, $315,977,675 Relative volume 20.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	POWL	+45.28%	2024-01-31 against the close of 2024-01-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Powell Industries Announces Fiscal 2024 First Quarter Results 01/30/2024 16:30 ET after hours Powell Industries Raises Quarterly Dividend to $0.2650 Per Share 01/30/2024	Day +1 +42.17% 2024-02-01 Day +5 +61.91% 2024-02-07 Best close within 5 +61.91% 2024-02-07 Five sessions later the move was 36.7% bigger, at +61.91%. Month end +45.27% on 2024-01-31 same session This month ended before the fifth session after the move.
Close before and after $27.20 to $39.51 split-adjusted Session open, high, low $33.42, $41.83, $33.42 Opening gap +22.87% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 4,709,901 shares, $186,088,189 Relative volume 10.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	LVTX	+42.95%	2024-01-25 against the close of 2024-01-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA® 01/25/2024 07:00 ET premarket	Day +1 +17.31% 2024-01-26 Day +5 +7.05% 2024-02-01 Best close within 5 +17.31% 2024-01-26 83.6% of the move was gone five sessions later. Month end +7.05% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $1.56 to $2.23 as traded Session open, high, low $2.31, $2.43, $2.02 Opening gap +48.08% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 43,378,213 shares, $96,733,415 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	MNTS	+41.86%	2024-01-31 against the close of 2024-01-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Momentus Completes All Requirements of the National Security Agreement (NSA) 01/31/2024 08:00 ET premarket	Day +1 +19.18% 2024-02-01 Day +5 +32.96% 2024-02-07 Best close within 5 +43.25% 2024-02-02 21.3% of the move was gone five sessions later. Month end +41.86% on 2024-01-31 same session This month ended before the fifth session after the move.
Close before and after $179.68 to $254.90 split-adjusted Session open, high, low $184.93, $317.37, $183.40 Opening gap +2.92% Close inside the session range 0.53 of the range, where 1.00 is the high Session volume 93,122 shares, $23,736,612 Relative volume 41.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	WGS	+40.36%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	GeneDx Announces Preliminary 2023 Financial Results 01/08/2024 08:55 ET premarket	Day +1 +62.91% 2024-01-09 Day +5 +21.09% 2024-01-16 Best close within 5 +62.91% 2024-01-09 47.7% of the move was gone five sessions later. Month end +40.00% on 2024-01-31
Close before and after $2.75 to $3.86 split-adjusted Session open, high, low $2.82, $3.92, $2.80 Opening gap +2.55% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 954,564 shares, $3,684,617 Relative volume 4.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
23	AEVA Also on the opposite board this month on both boards	+38.36%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Aeva Selected by Top Global Automotive OEM to Directly Supply LiDAR for its Series Production Program 01/03/2024 07:00 ET premarket	Day +1 +36.99% 2024-01-04 Day +5 +50.68% 2024-01-10 Best close within 5 +60.27% 2024-01-08 Five sessions later the move was 32.1% bigger, at +50.68%. Month end +16.71% on 2024-01-31
Close before and after $3.65 to $5.05 split-adjusted Session open, high, low $3.90, $5.30, $3.90 Opening gap +6.85% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 2,016,161 shares, $10,181,613 Relative volume 12.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	SASI	+37.93%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Sigma Additive Solutions Completes Acquisition of Travel Technology Company NextTrip Holdings 01/03/2024 08:30 ET premarket	Day +1 +43.10% 2024-01-04 Day +5 +33.79% 2024-01-10 Best close within 5 +56.21% 2024-01-05 10.9% of the move was gone five sessions later. Month end +16.55% on 2024-01-31
Close before and after $2.90 to $4.00 as traded Session open, high, low $4.69, $5.70, $3.75 Opening gap +61.72% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 14,054,143 shares, $56,216,572 Relative volume 626.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	MDIA	+36.95%	2024-01-02 against the close of 2023-12-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MediaCo Holding Inc. Announces Chris Squire as Senior Vice President of Sales and Marketing for HOT 97 and WBLS 01/02/2024 12:37 ET intraday	Day +1 +46.45% 2024-01-03 Day +5 +32.15% 2024-01-09 Best close within 5 +46.45% 2024-01-03 13.0% of the move was gone five sessions later. Month end +29.22% on 2024-01-31
Close before and after $0.4295 to $0.5882 split-adjusted Session open, high, low $0.4300, $0.9100, $0.4300 Opening gap +0.12% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 2,443,400 shares, $1,437,208 Relative volume 303.5x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
26	EVAX More than one ranked move this month 2+ ranked moves	+36.29%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Evaxion Announces Completion of ADS Ratio Change 01/22/2024 16:30 ET after hours	Day +1 +190.89% 2024-01-24 Day +5 +58.14% 2024-01-30 Best close within 5 +190.89% 2024-01-24 Five sessions later the move was 60.2% bigger, at +58.14%. Month end +7.34% on 2024-01-31
Close before and after $18.31 to $24.95 split-adjusted Session open, high, low $27.75, $27.85, $20.75 Opening gap +51.59% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 251,742 shares, $6,280,963 Relative volume 278.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	RUM More than one ranked move this month 2+ ranked moves	+36.21%	2024-01-22 against the close of 2024-01-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Rumble Announces Partnership With Barstool Sports 01/22/2024 09:00 ET premarket	Day +1 +81.06% 2024-01-23 Day +5 +80.78% 2024-01-29 Best close within 5 +81.06% 2024-01-23 Five sessions later the move was 123.1% bigger, at +80.78%. Month end +90.81% on 2024-01-31
Close before and after $3.59 to $4.89 split-adjusted Session open, high, low $4.02, $4.97, $3.80 Opening gap +11.98% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 23,577,541 shares, $115,294,175 Relative volume 15.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
28	SMCI	+35.94%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Supermicro Provides Second Quarter Fiscal 2024 Business Update 01/18/2024 16:05 ET after hours	Day +1 +40.07% 2024-01-22 Day +5 +52.24% 2024-01-26 Best close within 5 +52.70% 2024-01-25 Five sessions later the move was 45.4% bigger, at +52.24%. Month end +70.05% on 2024-01-31
Close before and after $31.14 to $42.34 split-adjusted Session open, high, low $34.76, $42.87, $33.89 Opening gap +11.60% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 231,125,170 shares, $9,784,915,197 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	AMSC Also on the opposite board this month on both boards	+35.90%	2024-01-25 against the close of 2024-01-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AMSC Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Business Outlook 01/24/2024 16:05 ET after hours	Day +1 +41.23% 2024-01-26 Day +5 +16.00% 2024-02-01 Best close within 5 +41.23% 2024-01-26 55.4% of the move was gone five sessions later. Month end +12.82% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $9.75 to $13.25 split-adjusted Session open, high, low $12.57, $13.80, $11.00 Opening gap +28.92% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 13,225,694 shares, $175,240,446 Relative volume 32.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	EWTX	+34.57%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock 01/19/2024 08:37 ET premarket	Day +1 +60.47% 2024-01-22 Day +5 +70.49% 2024-01-26 Best close within 5 +70.49% 2024-01-26 Five sessions later the move was 103.9% bigger, at +70.49%. Month end +84.00% on 2024-01-31
Close before and after $9.69 to $13.04 split-adjusted Session open, high, low $12.31, $13.75, $11.91 Opening gap +27.04% Close inside the session range 0.61 of the range, where 1.00 is the high Session volume 8,022,421 shares, $104,612,370 Relative volume 12.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	SYT Also on the opposite board this month on both boards	+33.82%	2024-01-12 against the close of 2024-01-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares 01/12/2024 09:00 ET premarket	Day +1 +12.71% 2024-01-16 Day +5 +1.20% 2024-01-22 Best close within 5 +30.70% 2024-01-18 96.5% of the move was gone five sessions later. Month end -1.68% on 2024-01-31
Close before and after $4.17 to $5.58 as traded Session open, high, low $4.04, $8.74, $4.04 Opening gap -3.12% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 5,426,576 shares, $30,280,294 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	RUM More than one ranked move this month 2+ ranked moves	+32.92%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Rumble Announces Public Launch of Rumble Studio 01/23/2024 08:00 ET premarket	Day +1 +16.16% 2024-01-24 Day +5 +24.54% 2024-01-30 Best close within 5 +32.72% 2024-01-29 25.5% of the move was gone five sessions later. Month end +40.08% on 2024-01-31
Close before and after $4.89 to $6.50 split-adjusted Session open, high, low $5.98, $7.02, $5.13 Opening gap +22.29% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 89,798,792 shares, $583,692,148 Relative volume 59.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	AMRN	+32.87%	2024-01-10 against the close of 2024-01-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024 01/10/2024 07:00 ET premarket	Day +1 +20.51% 2024-01-11 Day +5 +12.27% 2024-01-18 Best close within 5 +21.54% 2024-01-12 62.7% of the move was gone five sessions later. Month end +16.39% on 2024-01-31
Close before and after $19.42 to $25.80 split-adjusted Session open, high, low $22.40, $26.20, $22.00 Opening gap +15.36% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 790,043 shares, $20,383,109 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	ARDX	+32.79%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities 01/08/2024 08:00 ET premarket	Day +1 +47.73% 2024-01-09 Day +5 +42.53% 2024-01-16 Best close within 5 +47.73% 2024-01-09 Five sessions later the move was 29.7% bigger, at +42.53%. Month end +41.72% on 2024-01-31
Close before and after $6.16 to $8.18 split-adjusted Session open, high, low $6.50, $8.25, $6.46 Opening gap +5.52% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 26,122,216 shares, $213,679,727 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
35	SATS	+31.52%	2024-01-10 against the close of 2024-01-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	ECHOSTAR CORPORATION UNLOCKS INCREMENTAL STRATEGIC, FINANCIAL AND OPERATING FLEXIBILITY FOLLOWING COMPLETION OF MERGER WITH DISH NETWORK CORPORATION 01/10/2024 06:00 ET premarket DISH Wireless Awarded $50 Million NTIA Grant for 5G Open RAN Integration and Deployment Center 01/10/2024	Day +1 +27.01% 2024-01-11 Day +5 +36.02% 2024-01-18 Best close within 5 +38.23% 2024-01-17 Five sessions later the move was 14.3% bigger, at +36.02%. Month end +5.77% on 2024-01-31
Close before and after $12.66 to $16.65 as traded Session open, high, low $12.85, $17.90, $12.85 Opening gap +1.50% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 18,133,765 shares, $301,927,187 Relative volume 15.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	DYN	+31.28%	2024-01-04 against the close of 2024-01-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Dyne Therapeutics Announces Proposed Public Offering of Common Stock 01/03/2024 16:25 ET after hours	Day +1 +21.60% 2024-01-05 Day +5 +11.10% 2024-01-11 Best close within 5 +27.08% 2024-01-09 64.5% of the move was gone five sessions later. Month end +44.89% on 2024-01-31
Close before and after $14.77 to $19.39 split-adjusted Session open, high, low $14.37, $19.87, $14.29 Opening gap -2.71% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 14,050,352 shares, $272,436,325 Relative volume 22.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	PLUG	+30.99%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Plug Power Starts Production of Liquid Green Hydrogen at its Georgia Plant 01/23/2024 09:00 ET premarket	Day +1 +22.36% 2024-01-24 Day +5 +31.34% 2024-01-30 Best close within 5 +33.45% 2024-01-29 Five sessions later the move was 1.1% bigger, at +31.34%. Month end +56.69% on 2024-01-31
Close before and after $2.84 to $3.72 split-adjusted Session open, high, low $3.36, $3.82, $3.12 Opening gap +18.31% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 158,726,451 shares, $590,462,398 Relative volume 5.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	OTLK	+30.53%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010 01/23/2024 08:00 ET premarket	Day +1 +17.65% 2024-01-24 Day +5 +22.06% 2024-01-30 Best close within 5 +31.29% 2024-01-29 27.7% of the move was gone five sessions later. Month end +13.53% on 2024-01-31
Close before and after $6.80 to $8.88 split-adjusted Session open, high, low $8.20, $9.12, $7.64 Opening gap +20.59% Close inside the session range 0.83 of the range, where 1.00 is the high Session volume 1,389,132 shares, $12,329,936 Relative volume 30.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	TDCX	+30.43%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company 01/03/2024 06:05 ET premarket	Day +1 +30.43% 2024-01-04 Day +5 +34.37% 2024-01-10 Best close within 5 +34.58% 2024-01-08 Five sessions later the move was 12.9% bigger, at +34.37%. Month end +29.81% on 2024-01-31
Close before and after $4.83 to $6.30 as traded Session open, high, low $6.32, $6.54, $6.12 Opening gap +30.85% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 2,386,551 shares, $15,035,271 Relative volume 35.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	SHOT	+29.61%	2024-01-17 against the close of 2024-01-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Litigation Update - Safety Shot Authorized to Serve Notice of Action Against Capybara Research and Igor Appelboom by Public Disclosure and Press Release Pursuant to Court Order 01/16/2024 16:10 ET after hours Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders 01/17/2024	Day +1 +27.37% 2024-01-18 Day +5 +21.23% 2024-01-24 Best close within 5 +27.37% 2024-01-18 28.3% of the move was gone five sessions later. Month end +74.30% on 2024-01-31
Close before and after $1.79 to $2.32 split-adjusted Session open, high, low $1.85, $2.37, $1.85 Opening gap +3.35% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 7,088,320 shares, $16,444,902 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	VXRT	+29.41%	2024-01-16 against the close of 2024-01-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management 01/16/2024 09:25 ET premarket Vaxart, Inc. Announces Management Change 01/16/2024	Day +1 +37.83% 2024-01-17 Day +5 +42.05% 2024-01-23 Best close within 5 +42.05% 2024-01-23 Five sessions later the move was 43.0% bigger, at +42.05%. Month end +110.68% on 2024-01-31
Close before and after $0.5601 to $0.7248 split-adjusted Session open, high, low $0.6010, $0.8490, $0.5804 Opening gap +7.30% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 13,920,872 shares, $10,089,848 Relative volume 16.2x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
42	FLXS	+29.19%	2024-01-12 against the close of 2024-01-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Flexsteel Industries, Inc. Reports Strong Preliminary Results for Second Quarter; Forecasts Continued Sales Growth and Robust Profit Improvement 01/11/2024 16:10 ET after hours	Day +1 +33.16% 2024-01-16 Day +5 +62.93% 2024-01-22 Best close within 5 +62.93% 2024-01-22 Five sessions later the move was 115.6% bigger, at +62.93%. Month end +58.32% on 2024-01-31
Close before and after $18.02 to $23.28 split-adjusted Session open, high, low $21.88, $23.42, $21.15 Opening gap +21.42% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 113,202 shares, $2,635,343 Relative volume 8.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	ACCD	+29.00%	2024-01-09 against the close of 2024-01-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Accolade Announces Results for Fiscal Third Quarter 2024 01/08/2024 16:03 ET after hours	Day +1 +29.26% 2024-01-10 Day +5 +4.82% 2024-01-17 Best close within 5 +29.26% 2024-01-10 83.4% of the move was gone five sessions later. Month end -2.58% on 2024-01-31
Close before and after $11.62 to $14.99 as traded Session open, high, low $13.00, $15.04, $12.56 Opening gap +11.88% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 4,518,396 shares, $67,730,756 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	+28.77%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow 01/24/2024 08:30 ET premarket	Day +1 +17.81% 2024-01-25 Day +5 +4.93% 2024-01-31 Best close within 5 +17.81% 2024-01-25 82.9% of the move was gone five sessions later. Month end +4.93% on 2024-01-31
Close before and after $3.65 to $4.70 split-adjusted Session open, high, low $3.80, $4.78, $3.67 Opening gap +4.11% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 1,970,271 shares, $9,260,274 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	TCN	+28.27%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Blackstone Real Estate to Take Tricon Residential Private 01/19/2024 08:46 ET premarket	Day +1 +27.69% 2024-01-22 Day +5 +27.69% 2024-01-26 Best close within 5 +27.69% 2024-01-22 2.1% of the move was gone five sessions later. Month end +27.81% on 2024-01-31
Close before and after $8.63 to $11.07 as traded Session open, high, low $11.14, $11.15, $11.02 Opening gap +29.08% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 95,665,676 shares, $1,059,019,033 Relative volume 73.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	APPF	+28.26%	2024-01-26 against the close of 2024-01-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AppFolio, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results 01/25/2024 16:05 ET after hours	Day +1 +31.72% 2024-01-29 Day +5 +30.62% 2024-02-02 Best close within 5 +31.72% 2024-01-29 Five sessions later the move was 8.4% bigger, at +30.62%. Month end +25.74% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $174.38 to $223.66 split-adjusted Session open, high, low $201.00, $226.78, $198.01 Opening gap +15.27% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 1,858,775 shares, $415,733,617 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	SANM	+28.20%	2024-01-30 against the close of 2024-01-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sanmina's First Quarter Fiscal 2024 Financial Results 01/29/2024 16:02 ET after hours	Day +1 +18.15% 2024-01-31 Day +5 +14.95% 2024-02-06 Best close within 5 +20.76% 2024-02-02 47.0% of the move was gone five sessions later. Month end +18.15% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $50.63 to $64.91 split-adjusted Session open, high, low $60.00, $69.69, $59.11 Opening gap +18.51% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 4,806,066 shares, $311,961,744 Relative volume 12.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	SLDP	+27.35%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Solid Power Announces $50 Million Share Repurchase Authorization 01/23/2024 08:00 ET premarket	Day +1 +14.53% 2024-01-24 Day +5 +40.17% 2024-01-30 Best close within 5 +47.86% 2024-01-29 Five sessions later the move was 46.9% bigger, at +40.17%. Month end +38.46% on 2024-01-31
Close before and after $1.17 to $1.49 split-adjusted Session open, high, low $1.25, $1.57, $1.24 Opening gap +6.84% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 17,282,243 shares, $25,750,542 Relative volume 5.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	MAIA More than one ranked move this month 2+ ranked moves	+26.89%	2024-01-05 against the close of 2024-01-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024 01/05/2024 08:00 ET premarket	Day +1 +26.05% 2024-01-08 Day +5 -7.56% 2024-01-12 Best close within 5 +31.93% 2024-01-09 It gave back the whole move and closed 7.56% below the pre-news price. Month end +26.05% on 2024-01-31
Close before and after $1.19 to $1.51 split-adjusted Session open, high, low $1.23, $1.55, $1.22 Opening gap +3.36% Close inside the session range 0.88 of the range, where 1.00 is the high Session volume 1,160,263 shares, $1,751,997 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	+26.68%	2024-01-22 against the close of 2024-01-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Genius Group 2024 Financial Guidance: 110% Growth to $56m - $60m Revenue with Positive EBITDA 01/22/2024 08:30 ET premarket	Day +1 +25.00% 2024-01-23 Day +5 +44.52% 2024-01-29 Best close within 5 +60.96% 2024-01-24 Five sessions later the move was 66.9% bigger, at +44.52%. Month end +31.16% on 2024-01-31
Close before and after $2.92 to $3.70 split-adjusted Session open, high, low $3.27, $3.70, $3.06 Opening gap +11.82% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 1,330,322 shares, $4,920,861 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
51	AXGN	+26.67%	2024-01-05 against the close of 2024-01-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Guidance Change	Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 01/04/2024 16:45 ET after hours Axogen Announces Promotions on Research and Development Team 01/04/2024 Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 01/04/2024	Day +1 +27.26% 2024-01-08 Day +5 +17.04% 2024-01-12 Best close within 5 +27.26% 2024-01-08 36.1% of the move was gone five sessions later. Month end +43.26% on 2024-01-31
Close before and after $6.75 to $8.55 split-adjusted Session open, high, low $7.43, $8.74, $7.34 Opening gap +10.07% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 1,417,173 shares, $12,116,829 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	SRTS	+26.32%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million 01/23/2024 08:00 ET premarket	Day +1 +32.33% 2024-01-24 Day +5 +24.44% 2024-01-30 Best close within 5 +34.21% 2024-01-25 7.1% of the move was gone five sessions later. Month end +22.18% on 2024-01-31
Close before and after $2.66 to $3.36 split-adjusted Session open, high, low $3.30, $3.65, $3.10 Opening gap +24.06% Close inside the session range 0.47 of the range, where 1.00 is the high Session volume 821,835 shares, $2,761,366 Relative volume 13.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	CATX	+26.12%	2024-01-18 against the close of 2024-01-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement 01/18/2024 07:00 ET premarket Perspective Therapeutics Announces Proposed Public Offering 01/17/2024	Day +1 +9.42% 2024-01-19 Day +5 +17.86% 2024-01-25 Best close within 5 +17.86% 2024-01-25 31.6% of the move was gone five sessions later. Month end +85.71% on 2024-01-31
Close before and after $4.36 to $5.50 split-adjusted Session open, high, low $4.00, $5.69, $3.80 Opening gap -8.30% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 731,674 shares, $4,024,207 Relative volume 5.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	TGAN	+25.86%	2024-01-11 against the close of 2024-01-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Renesas to Acquire Transphorm to Expand its Power Portfolio with GaN Technology 01/11/2024 01:00 ET premarket	Day +1 +26.65% 2024-01-12 Day +5 +27.44% 2024-01-19 Best close within 5 +28.23% 2024-01-18 Five sessions later the move was 6.1% bigger, at +27.44%. Month end +27.70% on 2024-01-31
Close before and after $3.79 to $4.77 as traded Session open, high, low $4.79, $4.80, $4.69 Opening gap +26.39% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 7,605,103 shares, $36,276,341 Relative volume 112.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	BCRX	+25.62%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability 01/05/2024 16:01 ET after hours	Day +1 +22.17% 2024-01-09 Day +5 0.00% 2024-01-16 Best close within 5 +22.17% 2024-01-09 100.0% of the move was gone five sessions later. Month end -12.97% on 2024-01-31
Close before and after $6.09 to $7.65 split-adjusted Session open, high, low $6.30, $7.65, $6.12 Opening gap +3.45% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 12,028,295 shares, $92,016,457 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
56	ACRS Also on the opposite board this month on both boards	+25.54%	2024-01-16 against the close of 2024-01-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review 01/16/2024 07:00 ET premarket	Day +1 +27.71% 2024-01-17 Day +5 +38.53% 2024-01-23 Best close within 5 +38.53% 2024-01-23 Five sessions later the move was 50.9% bigger, at +38.53%. Month end +25.54% on 2024-01-31
Close before and after $0.9240 to $1.16 split-adjusted Session open, high, low $1.06, $1.25, $1.04 Opening gap +14.72% Close inside the session range 0.57 of the range, where 1.00 is the high Session volume 6,040,600 shares, $7,007,096 Relative volume 2.4x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
57	ATRA	+25.28%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Atara Biotherapeutics Announces $15 Million Registered Direct Offering 01/08/2024 09:00 ET premarket Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference 01/08/2024	Day +1 +31.35% 2024-01-09 Day +5 +60.97% 2024-01-16 Best close within 5 +62.39% 2024-01-12 Five sessions later the move was 141.2% bigger, at +60.97%. Month end +40.77% on 2024-01-31
Close before and after $11.08 to $13.88 split-adjusted Session open, high, low $11.04, $14.29, $11.04 Opening gap -0.29% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 239,306 shares, $3,320,371 Relative volume 2.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
58	GMDA	+25.17%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Gamida Cell Actively Pursuing Strategic Alternatives 01/29/2024 06:00 ET premarket	Day +1 +8.65% 2024-01-30 Day +5 -4.31% 2024-02-05 Best close within 5 +8.65% 2024-01-30 It gave back the whole move and closed 4.31% below the pre-news price. Month end +5.71% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $0.3643 to $0.4560 as traded Session open, high, low $0.3700, $0.4870, $0.3700 Opening gap +1.56% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 14,055,462 shares, $6,409,291 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
59	PRAX	+24.85%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio 01/08/2024 08:00 ET premarket	Day +1 +56.01% 2024-01-09 Day +5 +63.36% 2024-01-16 Best close within 5 +72.65% 2024-01-11 Five sessions later the move was 155.0% bigger, at +63.36%. Month end +73.20% on 2024-01-31
Close before and after $25.19 to $31.45 split-adjusted Session open, high, low $26.12, $34.95, $26.11 Opening gap +3.69% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 351,243 shares, $11,046,592 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
60	CDLX	+24.61%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results 01/29/2024 07:56 ET premarket	Day +1 +39.34% 2024-01-30 Day +5 +20.10% 2024-02-05 Best close within 5 +39.34% 2024-01-30 18.3% of the move was gone five sessions later. Month end +32.41% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $57.70 to $71.90 split-adjusted Session open, high, low $70.80, $78.70, $67.00 Opening gap +22.70% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 626,142 shares, $45,019,610 Relative volume 13.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
61	BARK	+24.00%	2024-01-09 against the close of 2024-01-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	BARK Reports Preliminary Third Quarter Fiscal Year 2024 Revenue Ahead of the ICR Conference 01/08/2024 16:00 ET after hours	Day +1 +19.44% 2024-01-10 Day +5 +18.85% 2024-01-17 Best close within 5 +21.66% 2024-01-11 21.5% of the move was gone five sessions later. Month end +33.04% on 2024-01-31
Close before and after $15.48 to $19.20 split-adjusted Session open, high, low $16.89, $20.30, $15.62 Opening gap +9.05% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 344,950 shares, $6,623,040 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	MBTC	+23.50%	2024-01-30 against the close of 2024-01-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting 01/30/2024 08:31 ET premarket	Day +1 +24.03% 2024-01-31 Day +5 +15.91% 2024-02-06 Best close within 5 +28.08% 2024-02-05 32.3% of the move was gone five sessions later. Month end +24.03% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $9.49 to $11.72 as traded Session open, high, low $11.19, $12.50, $11.19 Opening gap +17.91% Close inside the session range 0.40 of the range, where 1.00 is the high Session volume 17,597 shares, $206,237 Relative volume 17.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	RXST	+22.80%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance 01/07/2024 10:00 ET intraday	Day +1 +24.86% 2024-01-09 Day +5 +22.88% 2024-01-16 Best close within 5 +27.46% 2024-01-11 Five sessions later the move was 0.4% bigger, at +22.88%. Month end +23.37% on 2024-01-31
Close before and after $36.89 to $45.30 split-adjusted Session open, high, low $41.25, $45.43, $41.00 Opening gap +11.82% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 1,485,553 shares, $67,295,551 Relative volume 2.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
64	ACET	+22.73%	2024-01-04 against the close of 2024-01-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024 01/04/2024 07:00 ET premarket Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook 01/03/2024	Day +1 +37.50% 2024-01-05 Day +5 +72.73% 2024-01-11 Best close within 5 +96.02% 2024-01-09 Five sessions later the move was 220.0% bigger, at +72.73%. Month end +69.89% on 2024-01-31
Close before and after $28.16 to $34.56 split-adjusted Session open, high, low $32.00, $37.92, $31.36 Opening gap +13.64% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 206,365 shares, $7,131,974 Relative volume 8.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	CLNN	+22.07%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Clene Reports Significant Improvement in Vision and Cognition With CNM-Au8® Treatment in VISIONARY-MS Trial Long-Term Open Label Extension 01/08/2024 07:00 ET premarket	Day +1 +44.48% 2024-01-09 Day +5 +75.86% 2024-01-16 Best close within 5 +75.86% 2024-01-16 Five sessions later the move was 243.7% bigger, at +75.86%. Month end +70.34% on 2024-01-31
Close before and after $5.80 to $7.08 split-adjusted Session open, high, low $5.98, $7.39, $5.90 Opening gap +3.10% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 174,129 shares, $1,232,833 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
66	LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	+21.87%	2024-01-10 against the close of 2024-01-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Guidance Change	SEALSQ Announces FY 2023 Preliminary Unaudited Revenue of $30 Million, Marking a 29% Increase Over FY 2022 01/10/2024 09:00 ET premarket SEALSQ Launches a Revolutionary “On-Package” Semiconductor Provisioning Service Shortening Lead Time to 4 Weeks 01/10/2024	Day +1 +98.12% 2024-01-11 Day +5 +39.37% 2024-01-18 Best close within 5 +98.12% 2024-01-11 Five sessions later the move was 80.0% bigger, at +39.37%. Month end +22.50% on 2024-01-31
Close before and after $1.60 to $1.95 split-adjusted Session open, high, low $1.85, $2.29, $1.57 Opening gap +15.63% Close inside the session range 0.53 of the range, where 1.00 is the high Session volume 43,915,061 shares, $85,634,369 Relative volume 129.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	PCT	+21.67%	2024-01-16 against the close of 2024-01-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	PureCycle Provides Ironton Purification Facility Production Update 01/16/2024 08:45 ET premarket	Day +1 +34.58% 2024-01-17 Day +5 +35.00% 2024-01-23 Best close within 5 +37.08% 2024-01-22 Five sessions later the move was 61.5% bigger, at +35.00%. Month end +63.33% on 2024-01-31
Close before and after $2.40 to $2.92 split-adjusted Session open, high, low $2.72, $3.19, $2.56 Opening gap +13.33% Close inside the session range 0.57 of the range, where 1.00 is the high Session volume 9,797,530 shares, $28,608,788 Relative volume 3.2x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
68	RWLK	+21.57%	2024-01-05 against the close of 2024-01-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	First ReWalk Personal Exoskeleton Claim Paid by Medicare 01/05/2024 08:00 ET premarket	Day +1 +22.55% 2024-01-08 Day +5 +5.88% 2024-01-12 Best close within 5 +22.55% 2024-01-08 72.7% of the move was gone five sessions later. Month end -2.93% on 2024-01-31
Close before and after $1.02 to $1.24 as traded Session open, high, low $1.01, $1.28, $1.01 Opening gap -0.98% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 1,437,961 shares, $1,783,072 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	+21.37%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024 01/03/2024 07:00 ET premarket	Day +1 +17.09% 2024-01-04 Day +5 +66.67% 2024-01-10 Best close within 5 +66.67% 2024-01-10 Five sessions later the move was 212.0% bigger, at +66.67%. Month end +67.52% on 2024-01-31
Close before and after $1.17 to $1.42 split-adjusted Session open, high, low $1.26, $1.55, $1.24 Opening gap +7.69% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 12,403,582 shares, $17,613,086 Relative volume 89.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	+21.29%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	SEALSQ Announces Appointment of John O’Hara as Chief Financial Officer 01/23/2024 16:05 ET after hours	Day +1 +7.10% 2024-01-25 Day +5 +26.45% 2024-01-31 Best close within 5 +26.45% 2024-01-31 Five sessions later the move was 24.2% bigger, at +26.45%. Month end +26.45% on 2024-01-31
Close before and after $1.55 to $1.88 split-adjusted Session open, high, low $1.61, $1.97, $1.60 Opening gap +3.87% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 4,460,666 shares, $8,386,052 Relative volume 0.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	BFLY	+20.79%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3 01/08/2024 08:05 ET premarket	Day +1 +15.84% 2024-01-09 Day +5 +2.97% 2024-01-16 Best close within 5 +15.84% 2024-01-09 85.7% of the move was gone five sessions later. Month end -10.78% on 2024-01-31
Close before and after $1.01 to $1.22 split-adjusted Session open, high, low $1.09, $1.32, $1.05 Opening gap +7.43% Close inside the session range 0.64 of the range, where 1.00 is the high Session volume 6,253,178 shares, $7,628,877 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
72	EHTH	+20.79%	2024-01-26 against the close of 2024-01-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2023 01/26/2024 08:00 ET premarket	Day +1 +28.05% 2024-01-29 Day +5 +30.29% 2024-02-02 Best close within 5 +30.29% 2024-02-02 Five sessions later the move was 45.7% bigger, at +30.29%. Month end +21.86% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $5.58 to $6.74 split-adjusted Session open, high, low $6.37, $7.18, $6.23 Opening gap +14.16% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 1,994,575 shares, $13,443,436 Relative volume 7.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	AXNX	+20.48%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue 01/08/2024 07:00 ET premarket Axonics Announces Definitive Agreement to be Acquired by Boston Scientific 01/08/2024 Boston Scientific Announces Agreement to Acquire Axonics, Inc. 01/08/2024	Day +1 +19.94% 2024-01-09 Day +5 +18.71% 2024-01-16 Best close within 5 +19.94% 2024-01-09 8.6% of the move was gone five sessions later. Month end +17.91% on 2024-01-31
Close before and after $57.57 to $69.36 as traded Session open, high, low $68.96, $69.68, $68.38 Opening gap +19.78% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 14,478,107 shares, $1,004,201,502 Relative volume 31.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
74	CROX	+20.33%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Crocs, Inc. Expects Record Annual Revenues of ~$3.95B, Up Over 11% Year-Over-Year 01/08/2024 07:00 ET premarket	Day +1 +15.81% 2024-01-09 Day +5 +16.51% 2024-01-16 Best close within 5 +21.64% 2024-01-10 18.8% of the move was gone five sessions later. Month end +17.38% on 2024-01-31
Close before and after $86.46 to $104.03 split-adjusted Session open, high, low $98.50, $104.85, $96.02 Opening gap +13.93% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 7,257,957 shares, $755,045,267 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
75	MAIA More than one ranked move this month 2+ ranked moves	+20.33%	2024-01-17 against the close of 2024-01-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024 01/17/2024 09:00 ET premarket	Day +1 +2.44% 2024-01-18 Day +5 +14.63% 2024-01-24 Best close within 5 +18.70% 2024-01-23 28.0% of the move was gone five sessions later. Month end +21.95% on 2024-01-31
Close before and after $1.23 to $1.48 split-adjusted Session open, high, low $1.22, $1.61, $1.20 Opening gap -0.81% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 3,726,555 shares, $5,515,301 Relative volume 14.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	KIRK	+20.24%	2024-01-19 against the close of 2024-01-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Kirkland's Home Announces Holiday 2023 Comparable Sales Results 01/19/2024 07:00 ET premarket Kirkland's Home Promotes Amy Sullivan to CEO 01/19/2024	Day +1 +17.06% 2024-01-22 Day +5 +19.84% 2024-01-26 Best close within 5 +22.62% 2024-01-23 2.0% of the move was gone five sessions later. Month end +30.95% on 2024-01-31
Close before and after $2.52 to $3.03 as traded Session open, high, low $2.80, $3.08, $2.76 Opening gap +11.11% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 393,626 shares, $1,192,687 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	SOFI	+20.21%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	SoFi Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results 01/29/2024 07:00 ET premarket SoFi Breaks Down Barriers to Investing By Offering Alternative Investments 01/29/2024	Day +1 +10.24% 2024-01-30 Day +5 -0.52% 2024-02-05 Best close within 5 +10.24% 2024-01-30 It gave back the whole move and closed 0.52% below the pre-news price. Month end +2.76% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $7.62 to $9.16 split-adjusted Session open, high, low $8.82, $9.45, $8.62 Opening gap +15.75% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 286,380,920 shares, $2,623,249,227 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
78	AKYA	+20.09%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership catalyst from a later release the same session	Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform 01/07/2024 08:00 ET premarket Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow 01/07/2024 Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook 01/07/2024	Day +1 +16.17% 2024-01-09 Day +5 +2.54% 2024-01-16 Best close within 5 +21.94% 2024-01-11 87.4% of the move was gone five sessions later. Month end +17.32% on 2024-01-31
Close before and after $4.33 to $5.20 as traded Session open, high, low $4.96, $5.34, $4.77 Opening gap +14.55% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 769,464 shares, $4,001,213 Relative volume 5.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
79	ATAI	+19.86%	2024-01-02 against the close of 2023-12-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA) 01/02/2024 08:00 ET premarket	Day +1 +6.38% 2024-01-03 Day +5 +55.32% 2024-01-09 Best close within 5 +55.32% 2024-01-09 Five sessions later the move was 178.5% bigger, at +55.32%. Month end +26.24% on 2024-01-31
Close before and after $1.41 to $1.69 split-adjusted Session open, high, low $1.42, $1.69, $1.40 Opening gap +0.71% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 3,089,312 shares, $5,220,937 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
80	VYGR Also on the opposite board this month on both boards	+19.67%	2024-01-03 against the close of 2024-01-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference 01/03/2024 07:00 ET premarket	Day +1 +20.44% 2024-01-04 Day +5 -6.56% 2024-01-10 Best close within 5 +20.44% 2024-01-04 It gave back the whole move and closed 6.56% below the pre-news price. Month end -19.22% on 2024-01-31
Close before and after $9.00 to $10.77 split-adjusted Session open, high, low $9.31, $11.35, $9.21 Opening gap +3.44% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 3,725,081 shares, $40,119,122 Relative volume 26.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	EOLS	+19.65%	2024-01-17 against the close of 2024-01-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance 01/16/2024 17:28 ET after hours	Day +1 +13.52% 2024-01-18 Day +5 +11.51% 2024-01-24 Best close within 5 +15.92% 2024-01-22 41.4% of the move was gone five sessions later. Month end +21.67% on 2024-01-31
Close before and after $10.43 to $12.48 split-adjusted Session open, high, low $11.00, $12.81, $10.75 Opening gap +5.47% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 4,081,461 shares, $50,936,633 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	MOB Also on the opposite board this month on both boards	+19.63%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Mobilicom’s ICE Cybersecurity Software Drone Solutions Purchased by Israel’s Ministry of Defense 01/24/2024 07:00 ET premarket	Day +1 +12.27% 2024-01-25 Day +5 -23.93% 2024-01-31 Best close within 5 +12.27% 2024-01-25 It gave back the whole move and closed 23.93% below the pre-news price. Month end -23.93% on 2024-01-31
Close before and after $1.63 to $1.95 split-adjusted Session open, high, low $1.70, $2.00, $1.66 Opening gap +4.29% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 1,117,160 shares, $2,178,462 Relative volume 37.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	SNCE	+19.62%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment 01/29/2024 07:30 ET premarket	Day +1 +20.25% 2024-01-30 Day +5 +19.83% 2024-02-05 Best close within 5 +20.46% 2024-02-02 Five sessions later the move was 1.1% bigger, at +19.83%. Month end +19.62% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $4.74 to $5.67 as traded Session open, high, low $5.69, $5.75, $5.64 Opening gap +20.04% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 436,211 shares, $2,473,316 Relative volume 32.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
84	SAVE	+19.46%	2024-01-22 against the close of 2024-01-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	JetBlue and Spirit File Notice of Appeal 01/19/2024 17:00 ET after hours	Day +1 +23.20% 2024-01-23 Day +5 -9.73% 2024-01-29 Best close within 5 +23.20% 2024-01-23 It gave back the whole move and closed 9.73% below the pre-news price. Month end -5.84% on 2024-01-31
Close before and after $6.68 to $7.98 as traded Session open, high, low $7.07, $8.25, $6.60 Opening gap +5.84% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 61,645,095 shares, $491,927,858 Relative volume 18.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
85	EWCZ	+19.15%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	European Wax Center, Inc. Provides Update Ahead of Presentation at ICR Conference 2024 01/08/2024 06:00 ET premarket	Day +1 +18.00% 2024-01-09 Day +5 +17.23% 2024-01-16 Best close within 5 +19.85% 2024-01-11 10.0% of the move was gone five sessions later. Month end +14.15% on 2024-01-31
Close before and after $13.00 to $15.49 as traded Session open, high, low $13.48, $15.96, $13.30 Opening gap +3.69% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 1,933,929 shares, $29,956,560 Relative volume 2.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
86	CRBU	+19.09%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024 01/07/2024 11:00 ET intraday	Day +1 +19.09% 2024-01-09 Day +5 +8.71% 2024-01-16 Best close within 5 +23.65% 2024-01-10 54.4% of the move was gone five sessions later. Month end +27.18% on 2024-01-31
Close before and after $4.82 to $5.74 split-adjusted Session open, high, low $4.90, $5.75, $4.82 Opening gap +1.66% Close inside the session range 0.99 of the range, where 1.00 is the high Session volume 3,141,885 shares, $18,034,420 Relative volume 2.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
87	ONDS	+18.95%	2024-01-02 against the close of 2023-12-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Ondas Holdings' American Robotics Engaged in AUVSI's Green UAS Program to Certify Compliance with Highest Levels of Cybersecurity and Accelerate Adoption of Optimus System by U.S. Federal and State Agencies 01/02/2024 08:30 ET premarket	Day +1 +22.22% 2024-01-03 Day +5 +7.19% 2024-01-09 Best close within 5 +22.22% 2024-01-03 62.1% of the move was gone five sessions later. Month end -10.46% on 2024-01-31
Close before and after $1.53 to $1.82 split-adjusted Session open, high, low $1.57, $1.99, $1.48 Opening gap +2.61% Close inside the session range 0.67 of the range, where 1.00 is the high Session volume 902,729 shares, $1,642,967 Relative volume 2.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
88	HRTX More than one ranked move this month 2+ ranked moves	+18.86%	2024-01-24 against the close of 2024-01-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures 01/23/2024 20:00 ET after hours	Day +1 +21.82% 2024-01-25 Day +5 +9.55% 2024-01-31 Best close within 5 +21.82% 2024-01-25 49.4% of the move was gone five sessions later. Month end +9.55% on 2024-01-31
Close before and after $2.20 to $2.62 split-adjusted Session open, high, low $2.33, $2.62, $2.28 Opening gap +5.91% Close inside the session range 0.99 of the range, where 1.00 is the high Session volume 16,118,623 shares, $42,150,199 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	KYMR	+18.86%	2024-01-04 against the close of 2024-01-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	R&D Day Highlights Kymera’s Immunology Strategy and Emerging Pipeline of Novel, First-in-Class Oral Degraders Addressing Multiple Highly Prevalent Immuno-inflammatory Diseases 01/04/2024 07:00 ET premarket	Day +1 +18.69% 2024-01-05 Day +5 +20.35% 2024-01-11 Best close within 5 +27.12% 2024-01-10 Five sessions later the move was 7.9% bigger, at +20.35%. Month end +43.14% on 2024-01-31
Close before and after $22.90 to $27.22 split-adjusted Session open, high, low $23.08, $27.40, $22.35 Opening gap +0.79% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 1,599,429 shares, $43,536,457 Relative volume 1.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	KROS	+18.47%	2024-01-04 against the close of 2024-01-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Keros Therapeutics Announces Proposed Public Offering of Common Stock 01/03/2024 16:05 ET after hours Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock 01/03/2024	Day +1 +16.80% 2024-01-05 Day +5 +24.58% 2024-01-11 Best close within 5 +24.79% 2024-01-09 Five sessions later the move was 33.1% bigger, at +24.58%. Month end +34.17% on 2024-01-31
Close before and after $41.26 to $48.88 split-adjusted Session open, high, low $45.29, $49.58, $44.91 Opening gap +9.77% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 1,889,296 shares, $92,348,788 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	CKPT	+18.45%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market 01/29/2024 08:00 ET premarket	Day +1 +13.10% 2024-01-30 Day +5 +10.12% 2024-02-05 Best close within 5 +21.43% 2024-01-31 45.1% of the move was gone five sessions later. Month end +21.43% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $1.68 to $1.99 as traded Session open, high, low $1.69, $2.10, $1.68 Opening gap +0.60% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 2,983,534 shares, $5,937,233 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
92	WWW	+18.37%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Wolverine Worldwide Affirms Preliminary 2023 Financial Results in Line With Guidance 01/08/2024 06:30 ET premarket	Day +1 +15.52% 2024-01-09 Day +5 +11.13% 2024-01-16 Best close within 5 +17.34% 2024-01-11 39.4% of the move was gone five sessions later. Month end +8.15% on 2024-01-31
Close before and after $7.73 to $9.15 split-adjusted Session open, high, low $7.87, $9.28, $7.87 Opening gap +1.81% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 1,835,940 shares, $16,798,851 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
93	MDC	+18.37%	2024-01-18 against the close of 2024-01-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend catalyst from a later release the same session	Richmond American Announces its Debut Cedar Creek Community 01/17/2024 17:01 ET after hours M.D.C. HOLDINGS DECLARES QUARTERLY CASH DIVIDEND 01/17/2024	Day +1 +17.99% 2024-01-19 Day +5 +17.95% 2024-01-25 Best close within 5 +18.67% 2024-01-22 2.3% of the move was gone five sessions later. Month end +17.88% on 2024-01-31
Close before and after $53.09 to $62.84 as traded Session open, high, low $62.64, $63.00, $62.55 Opening gap +17.99% Close inside the session range 0.64 of the range, where 1.00 is the high Session volume 8,975,573 shares, $564,025,007 Relative volume 26.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	UNCY	+18.29%	2024-01-23 against the close of 2024-01-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones 01/23/2024 07:03 ET premarket	Day +1 +15.52% 2024-01-24 Day +5 +11.91% 2024-01-30 Best close within 5 +15.52% 2024-01-24 34.9% of the move was gone five sessions later. Month end +14.32% on 2024-01-31
Close before and after $8.31 to $9.83 split-adjusted Session open, high, low $8.70, $10.50, $8.63 Opening gap +4.69% Close inside the session range 0.64 of the range, where 1.00 is the high Session volume 117,934 shares, $1,159,291 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	BTDR	+18.29%	2024-01-29 against the close of 2024-01-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Bitdeer Announces Appointment of Jihan Wu as New Chief Executive Officer as Linghui Kong Transitions to Chief Business Officer 01/29/2024 08:30 ET premarket	Day +1 +18.16% 2024-01-30 Day +5 -8.82% 2024-02-05 Best close within 5 +18.16% 2024-01-30 It gave back the whole move and closed 8.82% below the pre-news price. Month end +7.76% on 2024-01-31 This month ended before the fifth session after the move.
Close before and after $7.60 to $8.99 split-adjusted Session open, high, low $7.87, $9.20, $7.20 Opening gap +3.55% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 3,178,579 shares, $28,575,425 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
96	NS	+18.25%	2024-01-22 against the close of 2024-01-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Sunoco LP to Acquire NuStar Energy L.P. in Transaction Valued at $7.3 Billion 01/22/2024 07:45 ET premarket	Day +1 +16.69% 2024-01-23 Day +5 +21.63% 2024-01-29 Best close within 5 +21.63% 2024-01-29 Five sessions later the move was 18.5% bigger, at +21.63%. Month end +22.02% on 2024-01-31
Close before and after $18.03 to $21.32 as traded Session open, high, low $21.39, $21.52, $20.06 Opening gap +18.64% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 8,135,319 shares, $173,445,001 Relative volume 25.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
97	XOS	+18.25%	2024-01-11 against the close of 2024-01-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Xos and ElectraMeccanica Announce Proposed Combination to Accelerate Xos’ Leadership Position in Manufacturing Commercial Electric Vehicles for Major U.S. Fleet Customers 01/11/2024 11:30 ET intraday	Day +1 +30.36% 2024-01-12 Day +5 +11.14% 2024-01-19 Best close within 5 +30.36% 2024-01-12 39.0% of the move was gone five sessions later. Month end +13.93% on 2024-01-31
Close before and after $7.18 to $8.49 split-adjusted Session open, high, low $7.37, $8.69, $6.98 Opening gap +2.58% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 48,240 shares, $409,558 Relative volume 1.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	HRTX More than one ranked move this month 2+ ranked moves	+18.08%	2024-01-08 against the close of 2024-01-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain 01/07/2024 17:00 ET after hours	Day +1 +27.68% 2024-01-09 Day +5 +24.29% 2024-01-16 Best close within 5 +27.68% 2024-01-09 Five sessions later the move was 34.3% bigger, at +24.29%. Month end +36.16% on 2024-01-31
Close before and after $1.77 to $2.09 split-adjusted Session open, high, low $1.96, $2.12, $1.77 Opening gap +10.73% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 13,279,411 shares, $27,753,969 Relative volume 6.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
99	TAYD	+17.99%	2024-01-10 against the close of 2024-01-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	TAYLOR DEVICES ANNOUNCES FISCAL YEAR 2024 SECOND QUARTER AND FIRST HALF RESULTS INCLUDING A RECORD HIGH FIRM ORDER BACKLOG AND STOCK REPURCHASE 01/10/2024 09:00 ET premarket	Day +1 +19.09% 2024-01-11 Day +5 +29.27% 2024-01-18 Best close within 5 +35.21% 2024-01-17 Five sessions later the move was 62.7% bigger, at +29.27%. Month end +30.67% on 2024-01-31
Close before and after $23.57 to $27.81 split-adjusted Session open, high, low $24.02, $28.65, $24.02 Opening gap +1.91% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 76,083 shares, $2,115,868 Relative volume 13.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	CLPT	+17.91%	2024-01-09 against the close of 2024-01-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Guidance Change	ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue 01/08/2024 16:05 ET after hours	Day +1 +10.30% 2024-01-10 Day +5 +17.43% 2024-01-17 Best close within 5 +19.65% 2024-01-16 2.7% of the move was gone five sessions later. Month end +10.30% on 2024-01-31
Close before and after $6.31 to $7.44 split-adjusted Session open, high, low $7.00, $7.65, $6.92 Opening gap +10.94% Close inside the session range 0.71 of the range, where 1.00 is the high Session volume 396,252 shares, $2,948,115 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 662 smaller events this month are held out of this month's eligible pool; switch to include them. 277 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

3 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

2 events were left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In January 2024, the median gainer had given back 10.5% of its move five sessions later; the largest catalyst group was Other Announcement, 33 of the 100 events, at a median of +26.7%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still above the pre-news close at day +5
Other Announcement	33	33.0%	+26.7%	+24.5%	81.8% of 33
Earnings	17	17.0%	+28.2%	+19.8%	94.1% of 17
M&A / Acquisition	14	14.0%	+31.0%	+30.6%	92.9% of 14
Offering / Dilution	9	9.0%	Fewer than 10 events in this group, so no figures are shown.
Clinical Trial Results	6	6.0%	Fewer than 10 events in this group, so no figures are shown.

8 other catalyst types, 21 events: Contract / Partnership, Leadership Change, Guidance Change, Buyback / Dividend, FDA & Regulatory, Reverse Merger / Shell, Uplisting / Compliance, Crypto & Treasury.

How much of the move survived

Horizon	Still above the pre-news close close to close	Median change since the measured close as a share of the move
Day +1	100.0% of 100	0.8% given back, of 100
Day +5	90.0% of 100	10.5% given back, of 100
Month end	88.7% of 97	0.3% given back, of 97
Month end falls before day +5 for 16 of these 97 events, so this row is not a later horizon than the one above it. 97 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside January 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Best move
LAES	3Guidance Change, Crypto & Treasury, Leadership Change	+21.87%
EVAX	2Other Announcement	+113.43%
RUM	2Contract / Partnership, Other Announcement	+36.21%
GNS	2M&A / Acquisition, Other Announcement	+28.77%
MAIA	2Other Announcement, Clinical Trial Results	+26.89%
HRTX	2FDA & Regulatory, Contract / Partnership	+18.86%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Best move
SLDB	2023-12, 2023-11	+68.42%
PAPL	2023-12, 2023-11	+50.68%
CVM	2023-12, 2023-10	+41.12%
MGTX	2023-12, 2023-10	+32.59%
PRCH	2023-12, 2023-11	+34.35%
CVRX	2023-12, 2023-11	+29.30%
LASE	2023-12, 2023-11	+30.32%
VERV	2023-11, 2023-10	+27.95%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

Industry

34 other industries, 36 events

Industry not known: 23.0%

2 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against December 2023

100 events in the comparable window.

December 2023 median +32.8%, selected from the 5,619 events in that month's eligible pool

January 2024 median +26.7%, 6.1 points below December 2023. January 2024's median is taken over the 100 ranked rows, selected from the 8,201 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.